BridgeBio Oncology Therapeutics, Inc. (BBOT) income statement
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.06 (+3.05%)
Close on Nov 19, 2026Market cap $149.12MP/E –Yield –
BridgeBio Oncology Therapeutics, Inc. financial ratios
See a number that looks wrong?